Delivery Order SPE2DB20D3303-SPE2DB25FZ9W4
Award Date
6/6/25
Potential Completion Date
6/30/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,778.22 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product, with a performance period ending on July 3, 2025. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,778.22 firm fixed-price delivery order is for the supply of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product, with a period of performance through June 30, 2025. The award is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is a firm fixed-price delivery order for the supply of ATTRUBY 356 MG TABLET 28S medical products. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $12,778.22 and a performance period ending on June 25, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the Department of Defense. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $12,778.22 and with a completion date of June 27, 2025. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product. Amerisourcebergen Drug Corp is a for-profit organization...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product. The contract has a performance period ending on May 22, 2025. The contract is not a set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor and is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is for the delivery of 4568039826 ATTRUBY 356 MG TABLET 28S. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a larger...
This federal contract award, valued at $2,388.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication APRETUDE ER 600MG 1S, with a period of performance through May 20, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $7,947.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of SOTYKTU 6 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,170.15, is for the delivery of APTIOM 800 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...